GPRO to acquire Prodesse Inc, a privately held provider of clinical tests for influenza and other infectious diseases for approximately $60M in cash. <a href="http://www.reuters.com/article/marketsNews/idCNN0631723520091006?rpc=44" rel="nofollow" target="_blank">http://www.reuters.com/article/marketsNews/idCNN0631723520091006?rpc=44</a>